Efficacy and Safety of mDCF as First-Line Therapy for HER2-Negative Advanced Gastric Cancer in Vietnam: A Real-World Retrospective Study

Efficacy and Safety of mDCF as First-Line Therapy for HER2-Negative Advanced Gastric Cancer in Vietnam: A Real-World Retrospective Study

Introduction For patients with advanced gastric cancer (AGC) who are HER2-negative and ineligible for targeted therapies, chemotherapy remains the cornerstone of treatment. The modified docetaxel, cisplatin, and fluorouracil (mDCF) regimen has been proposed as an effective and tolerable triplet regi...

Full description

Saved in:
Bibliographic Details
Main Authors: Thi Yen Le MD, PhD, Lan Anh Thi Dinh MD, Van Thi Nguyen MD, PhD, Chu Van Nguyen PhD, Thi Han Pham PhD, Oanh Thi Bui PhD, Thi Thu Huong Nguyen MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2025-08-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748251371771
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items